Publications

Concerted interactions between multiple gp41 trimers and the target cell lipidome may be required for HIV-1 entry.

Gorai, B., Sahoo, A. K., Srivastava, A., Dixit, N. M., & Maiti, P. K.

Bistability in virus–host interaction networks underlies the success of hepatitis C treatments.

Padmanabhan, P., Raja, R., & Dixit, N. M.

Transmitted HIV-1 is more pathogenic in heterosexual individuals than homosexual men.

James, A., & Dixit, N. M.

The quantitative landscape of the neutralizing antibody response to SARS-CoV-2.

Padmanabhan, P., Desikan, R., & Dixit, N. M.

Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection.

Desikan, R., Raja, R., & Dixit, N. M.

City-Scale Agent-Based Simulators for the Study of Non-Pharmaceutical Interventions in the Context of the COVID-19 Epidemic.

Agrawal, S., Bhandari, S., Bhattacharjee, A., Deo, A., Dixit, N. M., Harsha, P., … & Yasodharan, S.

Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection.

Saha, A., & Dixit, N. M.

Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.

Padmanabhan, P., Desikan, R., & Dixit, N. M.